Natriuretic and hypotensive effects of chronically administered alpha-human atrial natriuretic polypeptide in sodium-deplete or replete conscious spontaneously hypertensive rats.
In order to investigate the relationship between the hypotensive and natriuretic effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) and sodium state, alpha-hANP was chronically administered for 7 days using an osmotic minipump (100 ng/h) to spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) which had been fed either a low- (13.8 mumol/g) or high- (1380 mumol/g) sodium diet. Systolic blood pressure (SBP) and urinary sodium excretion (UNaV) were measured before and during infusion. The SBP in both SHR and WKY fell significantly within 1 day of infusion, and remained reduced for all 7 days, regardless of the sodium intake. The UNaV increased significantly in sodium-replete SHR and WKY compared with rats infused with vehicle, but remained unchanged in sodium-deplete rats. Extracellular fluid volume may be an important determining factor in the natriuretic action of alpha-hANP, but may not affect its hypotensive action.
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003243:Consciousness; D006973:Hypertension / Q000503:physiopathology*; D007022:Hypotension / Q000139:chemically induced*; D009318:Natriuresis / Q000187:drug effects*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012964:Sodium / Q000172:deficiency* / Q000378:metabolism; D013997:Time Factors
D009320:Atrial Natriuretic Factor; D012964:Sodium